financetom
Business
financetom
/
Business
/
BRIEF-Foxo Technologies Inc. Announces Acquisition Agreement To Acquire Vector Biosource Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Foxo Technologies Inc. Announces Acquisition Agreement To Acquire Vector Biosource Inc.
Sep 11, 2025 5:12 AM

Sept 11 (Reuters) - Foxo Technologies Inc ( FOXO ):

* FOXO TECHNOLOGIES INC. ( FOXO ) ANNOUNCES ACQUISITION AGREEMENT TO

ACQUIRE VECTOR BIOSOURCE INC.

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck's Winrevair Poised for Strong Launch Following US FDA Approval, UBS Says
Merck's Winrevair Poised for Strong Launch Following US FDA Approval, UBS Says
Mar 27, 2024
03:09 PM EDT, 03/27/2024 (MT Newswires) -- Merck's ( MRK ) Winrevair is poised for a strong launch after the US Food and Drug Administration approved the medicine with a clean label and no significant warning or risk evaluation and mitigation strategy program, UBS said in a note emailed Wednesday. Noting that concerns of potential gastrointestinal bleeding as a result...
Market Chatter: Artisan Partners Asset Management Increases Stake in Barry Callebaut
Market Chatter: Artisan Partners Asset Management Increases Stake in Barry Callebaut
Mar 27, 2024
02:59 PM EDT, 03/27/2024 (MT Newswires) -- Artisan Partners Asset Management ( APAM ) increased its shareholding in Barry Callebaut to 5.5% from 3% in February, Bloomberg News reported, citing SIX Exchange. Artisan Partners is the second largest stakeholder in the Swiss-Belgian chocolate maker behind Jacobs Holding, which owns a 30% stake, according to the report. Neither Artisan Partners nor...
MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products
MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products
Mar 27, 2024
03:06 PM EDT, 03/27/2024 (MT Newswires) -- MiMedx Group ( MDXG ) said Wednesday the US Food and Drug Administration affirmed that Axiofill, a human-derived particulate wound dressing, does not meet the regulatory requirements as a Human Cell, Tissue or Cellular or Tissue-based Product under Section 361 of the Public Health Service Act. The FDA issued its decision in a...
National Bank Reviews Pivotree's Q4 -- Trims Target to $3, Reiterates Outperform
National Bank Reviews Pivotree's Q4 -- Trims Target to $3, Reiterates Outperform
Mar 27, 2024
03:01 PM EDT, 03/27/2024 (MT Newswires) -- Pivotree ( PVTRF ) reported its Q4 results with soft top-line performance care of macro-related project delays and the continued transition away from legacy solutions. The company was able to offset that softness with cost optimizations and still delivered a positive adj. EBITDA. The sequential growth in the leading indicator PS bookings suggests...
Copyright 2023-2026 - www.financetom.com All Rights Reserved